Literature DB >> 21301206

Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancer.

Weiqiang Zhou1, I-Chau Liang, Nelson S Yee.   

Abstract

Histone deacetylases (HDACs) play important roles in the epigenetic control of development, and aberrant expression of HDACs has been implicated in human diseases including cancer. Among the mammalian HDACs, HDAC1 has been extensively studied, but its role in exocrine pancreatic morphogenesis and cancer is still poorly understood. The goal of this study is to determine the functional role of HDAC1 in normal development of exocrine pancreas using zebrafish as the model organism as well as in human pancreatic adenocarcinoma. The zebrafish germline loss-of-function mutation hdac1(hi1618) caused impaired cell cycle progression in pancreatic epithelia, resulting in growth arrest and dysmorphogenesis of exocrine pancreas. In human pancreatic adenocarcinoma tissues and cell lines, HDAC1 was expressed at variably elevated levels. RNA interference-induced silencing of HDAC1 diminished proliferation of the cancer cells and cell cycle progression. The proliferative arrest in the developing exocrine pancreas and pancreatic cancer cells was associated with up-regulated expression of the cyclin-dependent kinase inhibitors and the sonic hedgehog signaling components. This study indicates that HDAC1 is required for pancreatic epithelial proliferation in development and cancer. We hypothesize that aberrant expression of HDAC1 modulates the developmental and signaling pathways in exocrine pancreatic epithelia and consequently the genes required for cellular proliferation during development and progression of pancreatic neoplasia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21301206      PMCID: PMC3084970          DOI: 10.4161/cbt.11.7.14720

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  49 in total

1.  SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines.

Authors:  Ji Kon Ryu; Woo Jin Lee; Kwang Hyuck Lee; Jin-Hyeok Hwang; Yong-Tae Kim; Yong Bum Yoon; Chung Yong Kim
Journal:  Cancer Lett       Date:  2005-07-11       Impact factor: 8.679

2.  Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation.

Authors:  Gianluca Canettieri; Lucia Di Marcotullio; Azzura Greco; Sonia Coni; Laura Antonucci; Paola Infante; Laura Pietrosanti; Enrico De Smaele; Elisabetta Ferretti; Evelina Miele; Marianna Pelloni; Giuseppina De Simone; Emilia Maria Pedone; Paola Gallinari; Alessandra Giorgi; Christian Steinkühler; Luigi Vitagliano; Carlo Pedone; M Eugenià Schinin; Isabella Screpanti; Alberto Gulino
Journal:  Nat Cell Biol       Date:  2010-01-17       Impact factor: 28.824

3.  Downregulation of gelsolin and retinoic acid receptor beta expression in gastric cancer tissues through histone deacetylase 1.

Authors:  Jin-Hyun Kim; Yang-Kyu Choi; Ho-Jeong Kwon; Han-Kwang Yang; Jae-Hoon Choi; Dae-Yong Kim
Journal:  J Gastroenterol Hepatol       Date:  2004-02       Impact factor: 4.029

4.  Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation.

Authors:  Kotaro Miyake; Tomoharu Yoshizumi; Satoru Imura; Koji Sugimoto; Erdenebulgan Batmunkh; Hirofumi Kanemura; Yuji Morine; Mitsuo Shimada
Journal:  Pancreas       Date:  2008-04       Impact factor: 3.327

5.  Expression profile of class I histone deacetylases in human cancer tissues.

Authors:  Masamune Nakagawa; Yoshinao Oda; Takashi Eguchi; Shin-Ichi Aishima; Takashi Yao; Fumihito Hosoi; Yuji Basaki; Mayumi Ono; Michihiko Kuwano; Masao Tanaka; Masazumi Tsuneyoshi
Journal:  Oncol Rep       Date:  2007-10       Impact factor: 3.906

6.  Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos.

Authors:  Pengpeng Ma; Richard M Schultz
Journal:  Dev Biol       Date:  2008-04-18       Impact factor: 3.582

7.  Zebrafish as a model for pancreatic cancer research.

Authors:  Nelson S Yee; Michael Pack
Journal:  Methods Mol Med       Date:  2005

8.  Evolutionary conserved role of ptf1a in the specification of exocrine pancreatic fates.

Authors:  Elisabetta Zecchin; Anastasia Mavropoulos; Nathalie Devos; Alida Filippi; Natascia Tiso; Dirk Meyer; Bernard Peers; Marino Bortolussi; Francesco Argenton
Journal:  Dev Biol       Date:  2004-04-01       Impact factor: 3.582

9.  Transient receptor potential ion channel Trpm7 regulates exocrine pancreatic epithelial proliferation by Mg2+-sensitive Socs3a signaling in development and cancer.

Authors:  Nelson S Yee; Weiqiang Zhou; I-Chau Liang
Journal:  Dis Model Mech       Date:  2010-12-23       Impact factor: 5.758

10.  Expression profile of histone deacetylase 1 in gastric cancer tissues.

Authors:  J H Choi; H J Kwon; B I Yoon; J H Kim; S U Han; H J Joo; D Y Kim
Journal:  Jpn J Cancer Res       Date:  2001-12
View more
  11 in total

1.  KAT5 and KAT6B are in positive regulation on cell proliferation of prostate cancer through PI3K-AKT signaling.

Authors:  Wei He; Min-Guang Zhang; Xiao-Jing Wang; Shan Zhong; Yuan Shao; Yu Zhu; Zhou-Jun Shen
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

Review 2.  Targeting Histone Deacetylases in Diseases: Where Are We?

Authors:  Rosaria Benedetti; Mariarosaria Conte; Lucia Altucci
Journal:  Antioxid Redox Signal       Date:  2014-03-06       Impact factor: 8.401

Review 3.  Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Drug Discov Today       Date:  2012-08-10       Impact factor: 7.851

4.  Translating discovery in zebrafish pancreatic development to human pancreatic cancer: biomarkers, targets, pathogenesis, and therapeutics.

Authors:  Nelson S Yee; Abid A Kazi; Rosemary K Yee
Journal:  Zebrafish       Date:  2013-05-17       Impact factor: 1.985

Review 5.  Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments.

Authors:  Javier Martinez-Useros; Mario Martin-Galan; Maria Florez-Cespedes; Jesus Garcia-Foncillas
Journal:  Cancers (Basel)       Date:  2021-06-27       Impact factor: 6.639

6.  Aberrant over-expression of TRPM7 ion channels in pancreatic cancer: required for cancer cell invasion and implicated in tumor growth and metastasis.

Authors:  Nelson S Yee; Abid A Kazi; Qin Li; Zhaohai Yang; Arthur Berg; Rosemary K Yee
Journal:  Biol Open       Date:  2015-03-13       Impact factor: 2.422

Review 7.  Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications.

Authors:  Brittany R Silverman; Jiaqi Shi
Journal:  Int J Mol Sci       Date:  2016-12-19       Impact factor: 5.923

8.  Targeting developmental regulators of zebrafish exocrine pancreas as a therapeutic approach in human pancreatic cancer.

Authors:  Nelson S Yee; Weiqiang Zhou; Stephen G Chun; I-Chau Liang; Rosemary K Yee
Journal:  Biol Open       Date:  2012-02-10       Impact factor: 2.422

9.  The anti-tumor effect of HDAC inhibition in a human pancreas cancer model is significantly improved by the simultaneous inhibition of cyclooxygenase 2.

Authors:  Olivier Peulen; Arnaud Gonzalez; Paul Peixoto; Andrei Turtoi; Denis Mottet; Philippe Delvenne; Vincent Castronovo
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

Review 10.  TRPM7 and TRPM8 Ion Channels in Pancreatic Adenocarcinoma: Potential Roles as Cancer Biomarkers and Targets.

Authors:  Nelson S Yee; Ada S Chan; Julian D Yee; Rosemary K Yee
Journal:  Scientifica (Cairo)       Date:  2012-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.